Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.

While no significant group by test session interactions were present across measures, only the CVLT-II approached significance (F 1,220 = 5.21, p = 0.023).

also in 8,237 other papers

Marginally significant test session effects were present on the CVLT-II test of immediate verbal recall with both groups showing improvements in their T2 assessments ( Table 2 , Figure 3 ).

also in 26,082 other papers